• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Alzheimer's and Dementia Guidelines and Tables.阿尔茨海默病和痴呆症指南和表格。
Psychopharmacol Bull. 2023 Jul 12;53(2):8-65.
2
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.抗痴呆药物的临床应用:英国精神药理学会修订版(第三版)共识声明
J Psychopharmacol. 2017 Feb;31(2):147-168. doi: 10.1177/0269881116680924. Epub 2017 Jan 20.
3
Management of Depression in Patients with Dementia: Is Pharmacological Treatment Justified?痴呆患者抑郁症的管理:药物治疗是否合理?
Drugs Aging. 2017 Feb;34(2):89-95. doi: 10.1007/s40266-016-0434-6.
4
The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.专家共识指南系列。痴呆及其行为障碍的治疗。引言:方法、评论与总结。
Postgrad Med. 2005 Jan;Spec No:6-22.
5
Atypical antipsychotics for the treatment of dementia-related behaviors: an update.用于治疗痴呆相关行为的非典型抗精神病药物:最新进展
Med Health R I. 2007 Jun;90(6):191-4.
6
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.在痴呆症患者中,停用或继续使用胆碱酯酶抑制剂、美金刚或两者。
Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.
7
Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.非典型抗精神病药物超说明书使用的比较有效性评价综述
J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. doi: 10.18553/jmcp.2012.18.S5-B.1.
8
Pharmacological treatment of dementia.痴呆的药物治疗。
Curr Opin Psychiatry. 2012 Nov;25(6):542-50. doi: 10.1097/YCO.0b013e328358e4f2.
9
10
Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.阿尔茨海默病及其他神经退行性疾病所致痴呆——美金刚,新希望。
Pharmacol Res. 2005 Jan;51(1):1-17. doi: 10.1016/j.phrs.2004.05.005.

引用本文的文献

1
Monomeric and oligomeric amyloid-β cause distinct Alzheimer's disease pathophysiological characteristics in astrocytes in human glymphatics-on-chip models.单体和寡聚体淀粉样蛋白-β在人神经胶淋巴系统芯片模型的星形胶质细胞中引起不同的阿尔茨海默病病理生理学特征。
Lab Chip. 2024 Aug 6;24(16):3826-3839. doi: 10.1039/d4lc00287c.

阿尔茨海默病和痴呆症指南和表格。

Alzheimer's and Dementia Guidelines and Tables.

机构信息

Lon S. Schneider, MD, MS, is Della Martin Chair of Psychiatry and Neuroscience, and Professor of Psychiatry, Neurology, and Gerontology in Keck School of Medicine at the University of Southern California, Los Angeles, CA.

出版信息

Psychopharmacol Bull. 2023 Jul 12;53(2):8-65.

PMID:37489152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10363282/
Abstract

Introduction The purpose of this guide is to provide convenient and useful information on about Alzheimer's disease and dementias of late life. The information includes selected facts, diagnostic criteria tables, descriptions of selected tests and screens, guidelines, clinical pharmacological data and references. This guide is divided into several sections: Background factsDiagnostic aids and criteria for dementia diagnosesMedications used for Alzheimer's disease and dementia Basic information on marketed treatments is provided although the treatment may not be FDA approved for this use. Approved cholinesterase inhibitors, memantine, and monoclonal antibodies are listed. No treatment is recommended or endorsed, however. This guide does not address the evidence base for the efficacy of the treatments listed. : Except for treatments above, discussions of medications for people with dementia nearly always involve off label use. For example, antidepressants and antipsychotics are indicated in the FDA-approved prescribing information for major depression and schizophrenia, and not for depressive symptoms or the delusions or hallucinations occurring within the context of dementia with two exceptions. In these instances, the doses listed are for reference only and should not be considered as recommendations or appropriate use. Physicians should consult the product package labeling for any drug mentioned.

摘要

简介 本指南旨在提供有关老年痴呆症和痴呆症的便捷有用信息。信息包括选定的事实、诊断标准表、选定测试和筛查的描述、指南、临床药理学数据和参考资料。本指南分为以下几部分: 背景事实 痴呆症诊断的辅助工具和标准 用于治疗阿尔茨海默病和痴呆症的药物 提供了市售治疗方法的基本信息,尽管这些治疗方法可能未获得 FDA 批准用于这种用途。列出了已批准的胆碱酯酶抑制剂、美金刚和单克隆抗体。但是,没有推荐或认可任何治疗方法。本指南不涉及所列出治疗方法的疗效证据基础。 除上述治疗方法外,讨论痴呆症患者的药物治疗几乎总是涉及超说明书使用。例如,抗抑郁药和抗精神病药在 FDA 批准的用于重度抑郁症和精神分裂症的处方信息中有明确规定,而不是用于痴呆症伴有的抑郁症状或在痴呆症背景下出现的妄想或幻觉,只有两种情况除外。在这些情况下,列出的剂量仅供参考,不应被视为推荐或适当使用。医生应查阅所提到的任何药物的产品包装标签。